title: CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
authors.forename: Julia E
authors.initials: JE
authors.lastname: Maxson
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
authors.forename: Rhonda E
authors.initials: RE
authors.lastname: Ries
authors.affiliation: Children's Oncology Group, Monrovia, CA;
authors.forename: Yi-Cheng
authors.initials: YC
authors.lastname: Wang
authors.affiliation: Children's Oncology Group, Monrovia, CA;
authors.forename: Robert B
authors.initials: RB
authors.lastname: Gerbing
authors.affiliation: Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE;
authors.forename: E Anders
authors.initials: EA
authors.lastname: Kolb
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Thompson
authors.affiliation: Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
authors.forename: Jaime M
authors.initials: JM
authors.lastname: Guidry Auvil
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: Marco A
authors.initials: MA
authors.lastname: Marra
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: Yussanne
authors.initials: Y
authors.lastname: Ma
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: Zusheng
authors.initials: Z
authors.lastname: Zong
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Mungall
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: Richard
authors.initials: R
authors.lastname: Moore
authors.affiliation: Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada;
authors.forename: William
authors.initials: W
authors.lastname: Long
authors.affiliation: Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
authors.forename: Patee
authors.initials: P
authors.lastname: Gesuwan
authors.affiliation: Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
authors.forename: Tanja M
authors.initials: TM
authors.lastname: Davidsen
authors.affiliation: Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
authors.forename: Leandro C
authors.initials: LC
authors.lastname: Hermida
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
authors.forename: Seamus B
authors.initials: SB
authors.lastname: Hughes
authors.affiliation: Arkansas Children's Hospital Research Institute and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR;
authors.forename: Jason E
authors.initials: JE
authors.lastname: Farrar
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
authors.forename: Jerald P
authors.initials: JP
authors.lastname: Radich
authors.affiliation: Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD;
authors.forename: Malcolm A
authors.initials: MA
authors.lastname: Smith
authors.affiliation: Office of Cancer Genomics, National Cancer Institute, Bethesda, MD;
authors.forename: Daniela S
authors.initials: DS
authors.lastname: Gerhard
authors.affiliation: Children's Oncology Group, Monrovia, CA; Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO; and.
authors.forename: Alan S
authors.initials: AS
authors.lastname: Gamis
authors.affiliation: Children's Oncology Group, Monrovia, CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
authors.forename: Todd A
authors.initials: TA
authors.lastname: Alonzo
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Children's Oncology Group, Monrovia, CA;
authors.forename: Soheil
authors.initials: S
authors.lastname: Meshinchi
mesh_terms: D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D008297:Male; D009154:Mutation; D016184:Receptors, Colony-Stimulating Factor / Q000235:genetics*
chemical_list: D022762:CCAAT-Enhancer-Binding Proteins; C515848:CEBPA protein, human; C517047:CSF3R protein, human; D016184:Receptors, Colony-Stimulating Factor